Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-001955
Filing Date
2018-01-25
Accepted
2018-01-25 18:46:49
Documents
1
Period of Report
2018-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3949
  Complete submission text file 0000899243-18-001955.txt   6315
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Reporting) CIK: 0000019617 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 18549516
SIC: 6021 National Commercial Banks

Mailing Address 161 FIRST STREET, THIRD FLOOR CAMBRIDGE MA 02142
Business Address 161 FIRST STREET, THIRD FLOOR CAMBRIDGE MA 02142 617-337-4682
Solid Biosciences, LLC (Issuer) CIK: 0001707502 (see all company filings)

EIN.: 900943402
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVENUE NEW YORK NY 10017 212-270-6000
JPMC Strategic Investments II Corp (Reporting) CIK: 0001728848 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 18549515